GlobeNewswire

Vista Latin America signs major enterprise software agreement with Cinépolis, the world's fourth largest cinema chain

Dela

AUCKLAND, New Zealand and MORELIA, Mexico, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Vista Latin America, a subsidiary of Vista Entertainment Solutions Ltd, the world's leading cinema management software provider to the global cinema exhibition industry, is delighted to announce the signing of a five-year Enterprise Software Agreement with Mexico-based Cinépolis, the world's fourth largest cinema chain.

Vista Entertainment Solutions Ltd '(Vista Cinema') is a Vista Group International company (NZX:VGL) (ASX:VGL).

The Enterprise Agreement will cover all 625 of the cinema sites currently owned by Cinépolis throughout the world (5,170 screens), as well as future cinema sites. 

Vista Cinema CEO Kimbal Riley says the deal is a natural extension of the relationship Vista has had with Cinépolis since 2009.

"This Enterprise Agreement with our long-time customer Cinépolis is the latest development in our strategy to secure longer-term Vista partnerships. Through the term of the agreement, it will enable Cinépolis to implement at agreed fees all products in the full suite of Vista Cinema software. Cinépolis has also committed to implementing Vista Cinema in Brazil, the world's fifth largest cinema market. The deal also reinforces Vista's recent announcement to incorporate our long-term Latin American business partner into Vista Group." 

Co-CEO of Vista Latin America, Gustavo Ortega, says: "This agreement marks another step forward in our relationship with Cinépolis, enabling us to grow together as we both continue on a global journey of expansion."

"The signing of this agreement highlights Vista's ability to work in partnership with Cinépolis, one of the world's leading exhibitors and one that is continually using innovative technology to benefit their customers," says co-CEO of Vista Latin America, Armando Mejias.

"This deal sets out a path to continue our solid operation worldwide, which will involve bringing Brazil on board, and with the support of our joint Cinépolis-Vista partnership, will offer sustainable growth," says Cinépolis's Global IT Director, Gabriel Morales Becker.

About Vista Latin America 
Vista Latin America was created in 2017 following an acquisition agreement between Vista Entertainment Solutions Ltd and its long-term Mexican business partner Senda Dirección Tecnológica, SA de CV.  Senda was founded in Mexico City in 2002 by Armando Mejias and Gustavo Ortega, who continue to lead the new company. Prior to the formation of Vista Latin America, since 2003 Senda distributed Vista Cinema software in Mexico and in 14 other countries in the region.

About Vista Entertainment Solutions 
Vista Entertainment Solutions Ltd (Vista Cinema) is the world leader in cinema management software solutions with installations in more than 80 countries around the world and an estimated 38% global market share in the Large Cinema Circuit market. The Vista Cinema software product line comprises multiple modules, integrated and scalable, suited to cinema exhibitors operating 20+ screens and 100s of cinemas. Vista Cinema is head-quartered in Auckland, New Zealand and has subsidiaries incorporated in Los Angeles, London, Shanghai, Beijing, Cape Town and Mexico City. 
Website: www.vista.co
Twitter:   @VistaCinema
LinkedIn: www.linkedin.com/company/vista-entertainment-solutions

About Vista Group International:
Vista Group International (Vista Group) is a public company, listed on both the New Zealand and Australian stock exchanges (NZX:VGL) (ASX:VGL). The Group provides software and additional technology solutions across the global film industry. Cinema management software is provided by Vista Cinema, the core business of the Group. Movio (authority in moviegoer data analytics), Veezi (cloud-based SaaS software for the Independent Cinema Market), movieXchange (connecting the movie industry to simplify the promotion and sale of movie tickets), Maccs (film distribution software), Numero (box office reporting software for film distributors and cinemas), Cinema Intelligence (business intelligence solutions), Powster (creative studio and marketing platform for movie studios) and Flicks (moviegoer 'go to' portal for movie information) provide an innovative range of complementary products across additional film industry sectors, from production and distribution, to cinema exhibition through to the moviegoer experience. Vista Group has offices located in New Zealand (Auckland HQ), Sydney, Los Angeles, London, Shanghai, Beijing, Cape Town, Mexico City, the Netherlands and Romania.
Website: www.vistagroup.co 
LinkedIn: www.linkedin.com/company/vista-group-limited

About Cinépolis: 
Cinépolis is the world's 4th largest movie theater circuit, operating more than 5,170 screens in 14 countries and serving more than 317 million patrons annually. Cinépolis operates under four different brands that span the ultra-premium to the extreme value segments. It was the first cinema exhibitor in the world to pioneer the concept of premium and luxury movie theaters via its Cinépolis VIP brand. Cinépolis aspires to provide its patrons the best overall experience in filmed entertainment and employs a global workforce of 40,874 people to support its mission. Founded in 1971, Cinépolis headquarters is located in Morelia, Mexico.

Press Contacts:  
   
Vista Group International/Auckland, NZ                                      MBC/ Los Angeles
Christine Fenby Maggie Begley (for Vista Group International)
+64 21 727 006 +1 310-390-0101
christine.fenby@vista.co maggie@mbcprinc.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vista Group International Limited via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum